| 2024-04-25 | Abeona Therapeutics Inc. ABEO | Chief Financial Officer | 5,608 0.0189% | $3.14 | $17,609 | +37.3% | ||
| 2023-09-19 | Abeona Therapeutics Inc. ABEO | Chief Financial Officer | 3,000 0.0122% | $3.82 | $11,458 | +21.37% | ||
| 2022-11-18 | Abeona Therapeutics Inc. ABEO | Chief Financial Officer | 2,500 0.0315% | $4.00 | $10,000 | -19.31% | ||
| 2021-09-15 | Sale | Avenue Therapeutics, Inc. ATXI | Chief Financial Officer | 7,160 0.042% | $1.62 | $11,599 | -69.16% | |
| 2020-08-20 | Sale | Avenue Therapeutics, Inc. ATXI | Chief Financial Officer | 3,840 0.0235% | $12.13 | $46,579 | -60.88% | |
| 2020-03-10 | Avenue Therapeutics, Inc. ATXI | Chief Financial Officer | 1,889 0.0115% | $7.94 | $14,999 | +12.63% | ||
| 2020-03-09 | Avenue Therapeutics, Inc. ATXI | Chief Financial Officer | 1,500 0.0093% | $7.99 | $11,983 | +13.49% | ||
| 2020-02-25 | Avenue Therapeutics, Inc. ATXI | Chief Financial Officer | 1,200 0.0074% | $9.09 | $10,908 | -0.89% | ||
| 2019-08-09 | Sale | Avenue Therapeutics, Inc. ATXI | Chief Financial Officer | 2,375 0.0138% | $5.56 | $13,205 | +49.32% | |
| 2019-08-08 | Sale | Avenue Therapeutics, Inc. ATXI | Chief Financial Officer | 2,313 0.0141% | $5.62 | $12,999 | +55.35% |